Ekso Bionics Holdings Inc expected to post a loss of 25 cents a share - Earnings Preview

Chronoscale

27/10/2021 08:04

* Ekso Bionics Holdings Inc  EKSO.OQ   EKSO.O  is expected
to show a fall in quarterly revenue when it reports results on
November 2. 
* The Richmond California, California-based company is expected
to report  a 11.0% decrease in revenue to $2.577 million from
$2.9 million a year ago, according to the estimate from one
analyst, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Ekso Bionics Holdings
Inc is for a loss of 25 cents per share. For the same quarter
last year, the company reported earnings of 30 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Ekso Bionics
Holdings Inc is $11​, about 63.6% above​ its last closing price
of $4.00. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.25       -0.25      -0.19     Beat    24
 Mar. 31 2021  -0.24       -0.24      -0.34     Missed  -41.7
 Dec. 31 2020  -0.30       -0.30      -0.48     Missed  -60​
 Sep. 30 2020  -0.39       -0.39      0.30      Beat    176.9
 Jun.          -0.55​      -0.55      -1.88     Missed  -238.7
 30​ 2020​                                              ​
 Mar. 31 2020  -0.61       -0.61      -0.44     Beat    27.9​
 Dec. 31 2019  -0.66       -0.65      -0.60     Beat    7.7
 Sep. 30 2019  -0.90       -1.05      0.00      Beat    100
 This summary was machine generated October 27 at 07:04 GMT.  All
figures in US dollars unless otherwise stated